USA Today (5/24, Bowerman) reports that “letting a baby cry it out, or cry until the child drifts off to sleep, does not cause long-term emotional or behavioral harm,” the findings of a study published online May 24 in Pediatrics suggest. After testing “the controversial sleep method of crying it out, and another commonly used sleep method on a group of 43 infants spanning from six months to 16 months,” investigators learned that babies “whose parents used ‘graduated extinction,’ or those who allowed their child to cry for increasingly long periods of time, were no more stressed than babies whose parents used bedtime fading, or the technique of moving bedtime later in hope that the child will fall asleep more quickly.”

In the New York Times (5/24) “Well” blog, Perri Klass, MD, writes that while graduated extinction and bedtime fading both “decreased the time it took children to fall asleep and graduated extinction reduced night wakings,” there is no seeming evidence that “you do harm by deciding to forgo ‘sleep training’ and waiting for the child to outgrow the night waking – as long as that doesn’t damage your marriage or your mental health.”

Related Links:

— “Study: Letting baby ‘cry it out’ won’t cause damage,” Mary Bowerman, USA Today, May 27, 2016.

The Wall Street Journal (5/23, Reddy, Subscription Publication) reports that two studies published in JAMA Psychiatry suggest that people who are diagnosed with AD/HD as adults may have a condition that is different than the AD/HD diagnosed in kids.

Reuters (5/23, Rapaport) says that one study included approximately 5,200 people, while the other study looked at more than 2,000 twins.

Related Links:

— “Can Adults Get a Different Kind of ADHD?,” Sumathi Reddy, Wall Street Journal, May 23, 2016.

In a greater than 2,600-word “Watchdog” investigative article, the Milwaukee Journal Sentinel (5/21, Fauber, Fiore) reported on the dangers of abuse and dependence in adults posed by some medications for the treatment of attention-deficit/hyperactivity disorder (AD/HD). Currently, medications to treat AD/HD “have become one of the most lucrative sectors of the US drug market, totaling more than $10 billion in sales and 83 million prescriptions in 2014, according to data from IMS Health,” with adults more of these medications to treat AD/HD. The article also pointed out that the “2013 edition of the Diagnostic and Statistical Manual of Mental Disorders, published by the American Psychiatric Association, relaxed the definition for” AD/HD in adults.

Related Links:

— “Drugs for treatment of adult ADHD carry risk of dependence, abuse,” John Fauber and Kristina Fiore, Milwaukee Journal Sentinel, May 22, 2016.

In an opinion piece for TIME (5/20), Rep. Eddie Bernice Johnson (D-TX) wrote that May is recognized as Mental Health Awareness Month. Johnson added, “At a time when America’s mental healthcare system is in need of major reform, I want to take this opportunity to discuss the stigma surrounding mental health disorders.” The congresswoman called for treating “mental health with serious questions, serious empathy and immediate responses.”

Related Links:

— “Rep. Johnson: How to End the Stigma of Mental-Health Disorders,” Rep. Eddie Bernice Johnson, Time, May 20, 2016.

Medscape (5/19, Anderson) reports that at a poster session at the American Psychiatric Association’s annual meeting, Canadian researchers detailed how they “have incorporated real-time analytics to better determine the risk for violence in psychiatric patients.” Investigators adapted a tool “developed for risk management in the forensic psychiatric setting…for use in general psychiatry and in the community” to predict, assess, and manage “risk for violence.” They then worked with an analytics company to “click on a mouse and see how a particular patient has done in the last month or the last year, and…watch any change in any of the risk factors” for violence.

Related Links:

— Medscape (requires login and subscription)